MedTrace Logo

Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding

NCT04499898 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2020-08-05

No results posted yet for this study

Summary

Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension

Conditions

  • Esophageal Varices

Interventions

DRUG

Carvedilol

Carvedilol

PROCEDURE

Endoscopic band ligation

Endoscopic band ligation

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Asem Elfert, Prof · Tanta University - Faculty of Medicine

  • Nabila Abd El-Nasser Abd El-Wahed El-Gazzar, ass. lect · Tanta University Faculty of medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2030-12-01
Completion
2030-12-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04499898 on ClinicalTrials.gov